Ovarian hyperstimulation syndrome

Nuria Pellicer, Daniela Galliano, António Pellicer
The Lancet · 2018 · vol. 338(8775) , pp. 345–362 · doi:10.1016/b978-0-12-813209-8.00022-4 · PMID:1682546 · W4256189710
Other OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-17 ⓘ

This review discusses the pathophysiology, clinical manifestations, and management strategies for ovarian hyperstimulation syndrome (OHSS), a potential complication of assisted reproductive technologies.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Ovarian Hyperstimulation Syndrome Female Fertility Agents, Female Fertility Agents, Female Humans Ovarian Hyperstimulation Syndrome Ovarian Hyperstimulation Syndrome Ovarian Hyperstimulation Syndrome Weight Gain

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (100)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-10-08T21:03:51.313027+00:00
unpaywall
last seen: 2026-10-18T06:28:46.490043+00:00
License: CC0 · commercial use OK